Manifestations of HIV infection in the peripheral nervous system

The Lancet Neurology

Volumn 12, Issue 3, 2013, Pages 295-309

  Centner, Chad M ^a   Bateman, Kathleen J ^a   Heckmann, Jeannine M ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CORTICOSTEROID; ISONIAZID;

ACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY; AUTONOMIC NEUROPATHY; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CRANIAL NEUROPATHY; DIFFERENTIAL DIAGNOSIS; DIFFUSE INFILTRATIVE LYMPHOCYTOSIS SYNDROME; DISTAL AXONAL SENSORIMOTOR POLYNEUROPATHY; DISTAL SENSORY POLYNEUROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUMBOSACRAL RADICULOPATHY; NEUROMUSCULAR WEAKNESS SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; RADICULOPATHY; REVIEW; TUBERCULOSIS; DRUG COMBINATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; METHODOLOGY;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES;

MLCS; MLOWN;

EID: 84876329419     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(13)70002-4     Document Type: Review

References (136)

1. McArthur JC, Steiner J, Sacktor N, Nath A Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol 2010, 67:699-714.
2. Brew BJ The peripheral nerve complications of human immunodeficiency virus (HIV) infection. Muscle Nerve 2003, 28:542-552.
3. Simpson DM, Tagliati M Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9:153-161.
4. Arenas-Pinto A, Bhaskaran K, Dunn D, Weller IV The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial. Antivir Ther 2008, 13:289-295.
5. Simpson DM, Kitch D, Evans SR, et al. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology 2006, 66:1679-1687.
6. Smyth K, Affandi JS, McArthur JC, et al. Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006. HIV Med 2007, 8:367-373.
7. Affandi JS, Price P, Imran D, Yunihastuti E, Djauzi S, Cherry CL Can we predict neuropathy risk before stavudine prescription in a resource-limited setting?. AIDS Res Hum Retroviruses 2008, 24:1281-1284.
8. Wright E, Brew B, Arayawichanont A, et al. Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology 2008, 71:50-56.
9. Cherry CL, Affandi JS, Imran D, et al. Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology 2009, 73:315-320.
10. Ellis RJ, Rosario D, Clifford DB, et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol 2010, 67:552-558.
11. Maritz J, Benatar M, Dave JA, et al. HIV neuropathy in South Africans: frequency, characteristics, and risk factors. Muscle Nerve 2010, 41:599-606.
12. Wadley AL, Cherry CL, Price P, Kamerman PR HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans. J Pain Symptom Manage 2011, 41:700-706.
13. Mullin S, Temu A, Kalluvya S, Grant A, Manji H High prevalence of distal sensory polyneuropathy in antiretroviral-treated and untreated people with HIV in Tanzania. Trop Med Int Health 2011, 16:1291-1296.
14. Mehta SA, Ahmed A, Laverty M, Holzman RS, Valentine F, Sivapalasingam S Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapy. Clin Infect Dis 2011, 53:490-496.
15. Evans SR, Ellis RJ, Chen H, et al. Peripheral neuropathy in HIV: prevalence and risk factors. AIDS 2011, 25:919-928.
16. Anziska Y, Helzner EP, Crystal H, et al. The relationship between race and HIV-distal sensory polyneuropathy in a large cohort of US women. J Neurol Sci 2012, 315:129-132.
17. Oshinaike O, Akinbami A, Ojo O, et al. Influence of age and neurotoxic HAART use on frequency of HIV sensory neuropathy. AIDS Res Treat 2012, published online Feb 20. 10.1155/2012/961510.
18. Choi Y, Townend J, Vincent T, et al. Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa. J Neurovirol 2011, 17:166-175.
19. Forna F, Liechty CA, Solberg P, et al. Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr 2007, 44:456-462.
20. Phan V, Thai S, Choun K, Lynen L, van Griensven J Incidence of treatment-limiting toxicity with stavudine-based antiretroviral therapy in Cambodia: a retrospective cohort study. PLoS One 2012, 7:e30647.
21. Winston A, McAllister J, Amin J, Cooper DA, Carr A The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis. HIV Med 2005, 6:191-197.
22. Van Dyke RB, Wang L, Williams PL, Pediatric ACTGCT Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children. J Infect Dis 2008, 198:1599-1608.
23. Benatar M Distal symmetric polyneuropathy: limitations of the proposed case definition. Muscle Nerve 2006, 34:131-144.
24. Cherry CL, Wesselingh SL, Lal L, McArthur JC Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Neurology 2005, 65:1778-1781.
25. Pardo CA, McArthur JC, Griffin JW HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst 2001, 6:21-27.
26. Kamerman PR, Moss PJ, Weber J, Wallace VC, Rice AS, Huang W Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models. J Peripher Nerv Syst 2012, 17:19-31.
27. Jones G, Zhu Y, Silva C, et al. Peripheral nerve-derived HIV-1 is predominantly CCR5-dependent and causes neuronal degeneration and neuroinflammation. Virology 2005, 334:178-193.
28. Keswani SC, Polley M, Pardo CA, Griffin JW, McArthur JC, Hoke A Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol 2003, 54:287-296.
29. Melli G, Keswani SC, Fischer A, Chen W, Hoke A Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy. Brain 2006, 129:1330-1338.
30. Acharjee S, Noorbakhsh F, Stemkowski PL, et al. HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain. FASEB J 2010, 24:4343-4353.
31. Lehmann HC, Chen W, Borzan J, Mankowski JL, Hoke A Mitochondrial dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathy. Ann Neurol 2011, 69:100-110.
32. Bhangoo SK, Ren D, Miller RJ, et al. CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy. Brain Behav Immun 2007, 21:581-591.
33. Wallace VC, Blackbeard J, Pheby T, et al. Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain 2007, 133:47-63.
34. Morgello S, Estanislao L, Simpson D, et al. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol 2004, 61:546-551.
35. Lichtenstein KA, Armon C, Baron A, et al. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis 2005, 40:148-157.
36. Robinson-Papp J, Tan IL, Simpson DM Neuromuscular complications in HIV: effects of aging. J Neurovirol 2012, 18:331-338.
37. Evans SR, Lee AJ, Ellis RJ, et al. HIV peripheral neuropathy progression: protection with glucose-lowering drugs?. J Neurovirol 2012, 18:428-433.
38. Kamerman PR, Wadley AL, Cherry CL HIV-associated sensory neuropathy: risk factors and genetics. Curr Pain Headache Rep 2012, 16:226-236.
39. Robinson-Papp J, Simpson DM Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve 2009, 40:1043-1053.
40. Banerjee S, McCutchan JA, Ances BM, et al. Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathy. AIDS 2011, 25:F1-F6.
41. Kumar N Nutritional neuropathies. Neurol Clin 2007, 25:209-255.
42. Van der Watt JJ, Harrison TB, Benatar M, Heckmann JM Polyneuropathy, anti-tuberculosis treatment and the role of pyridoxine in the HIV/AIDS era: a systematic review. Int J Tuberc Lung Dis 2011, 15:722-728.
43. Lanternier F, Dalban C, Perez L, Bricaire F, Costagliola D, Caumes E Tolerability of anti-tuberculosis treatment and HIV serostatus. Int J Tuberc Lung Dis 2007, 11:1203-1209.
44. Marks DJ, Dheda K, Dawson R, Ainslie G, Miller RF Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs. Int J STD AIDS 2009, 20:339-345.
45. Pettersen JA, Jones G, Worthington C, et al. Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity. Ann Neurol 2006, 59:816-824.
46. Ellis RJ, Marquie-Beck J, Delaney P, et al. Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol 2008, 64:566-572.
47. Robinson-Papp J, Gelman BB, Grant I, et al. Substance abuse increases the risk of neuropathy in an HIV-infected cohort. Muscle Nerve 2012, 45:471-476.
48. Ferrari LF, Levine JD Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms. Eur J Neurosci 2010, 32:811-818.
49. Robinson-Papp J, Gonzalez-Duarte A, Simpson DM, Rivera-Mindt M, Morgello S, Manhattan HIVBB The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: a pilot study. J Acquir Immune Defic Syndr 2009, 51:569-573.
50. Cherry CL, Affandi JS, Brew BJ, et al. Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV. Neurology 2010, 74:1538-1542.
51. Silva MT, Neves ES, Grinsztejn B, de Melo Espindola O, Schor D, Araujo A Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1. AIDS 2012, 26:521-523.
52. Zehender G, Colasante C, Santambrogio S, et al. Increased risk of developing peripheral neuropathy in patients coinfected with HIV-1 and HTLV-2. J Acquir Immune Defic Syndr 2002, 31:440-447.
53. Tagliati M, Grinnell J, Godbold J, Simpson DM Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. Arch Neurol 1999, 56:84-89.
54. Biraguma J, Rhoda A Peripheral neuropathy and quality of life of adults living with HIV/AIDS in the Rulindo district of Rwanda. SAHARA-J 2012, 9:88-94.
55. Robinson-Papp J, Morgello S, Vaida F, et al. Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy. Pain 2010, 151:732-736.
56. Keltner JR, Vaida F, Ellis RJ, et al. Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity. Psychosomatics 2012, 53:380-386.
57. Hahn K, Arendt G, Braun JS, et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol 2004, 251:1260-1266.
58. Phillips TJ, Cherry CL, Cox S, Marshall SJ, Rice AS Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS One 2010, 5:e14433.
59. Shlay JC Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy. JAMA 1998, 280:1590.
60. Simpson DM, McArthur JC, Olney R, et al. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology 2003, 60:1508-1514.
61. Simpson DM, Schifitto G, Clifford DB, et al. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology 2010, 74:413-420.
62. Simpson DM, Brown S, Tobias J, Group N-CS Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 2008, 70:2305-2313.
63. Clifford DB, Simpson DM, Brown S, et al. A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy. J Acquir Immune Defic Syndr 2012, 59:126-133.
64. McArthur JC, Yiannoutsos C, Simpson DM, et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology 2000, 54:1080-1088.
65. Youle M, Osio M, Group AS A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection. HIV Med 2007, 8:241-250.
66. Ellis RJ, Toperoff W, Vaida F, et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology 2009, 34:672-680.
67. Cepeda MS, Berlin JA, Gao CY, Wiegand F, Wada DR Placebo response changes depending on the neuropathic pain syndrome: results of a systematic review and meta-analysis. Pain Med 2012, 13:575-595.
68. Lucey BP, Clifford DB, Creighton J, Edwards RR, McArthur JC, Haythornthwaite J Relationship of depression and catastrophizing to pain, disability, and medication adherence in patients with HIV-associated sensory neuropathy. AIDS Care 2011, 23:921-928.
69. Koeppe J, Lyda K, Johnson S, Armon C Variables associated with decreasing pain among persons living with human immunodeficiency virus: a longitudinal follow-up study. Clin J Pain 2012, 28:32-38.
70. Nicholas PK, Voss J, Wantland D, et al. Prevalence, self-care behaviors, and self-care activities for peripheral neuropathy symptoms of HIV/AIDS. Nurs Health Sci 2010, 12:119-126.
71. Backonja MM, Irving G, Argoff C Rational multidrug therapy in the treatment of neuropathic pain. Curr Pain Headache Rep 2006, 10:34-38.
72. Ownby KK, Dune LS The processes by which persons with HIV-related peripheral neuropathy manage their symptoms: a qualitative study. J Pain Symptom Manage 2007, 34:48-59.
73. Lichtenstein KA, Armon C, Buchacz K, et al. Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency. J Acquir Immune Defic Syndr 2008, 47:27-35.
74. Mehta SA, Ahmed A, Kariuki BW, et al. Implementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, Kenya. Am J Trop Med 2010, 83:565-570.
75. Kandiah PA, Atadzhanov M, Kvalsund MP, Birbeck GL Evaluating the diagnostic capacity of a single-question neuropathy screen (SQNS) in HIV positive Zambian adults. J Neurol Neurosurg Psychiatry 2010, 81:1380-1381.
76. Brannagan TH, Zhou Y HIV-associated Guillain-Barré syndrome. J Neurol Sci 2003, 208:39-42.
77. Schleicher GK, Black A, Mochan A, Richards GA Effect of human immunodeficiency virus on intensive care unit outcome of patients with Guillain-Barré syndrome. Crit Care Med 2003, 31:1848-1850.
78. Griffin JW, Wesselingh SL, Griffin DE, Glass JD, McArthur JC Peripheral nerve disorders in HIV infection. Similarities and contrasts with CNS disorders. Res Publ Assoc Res Nerv Ment Dis 1994, 72:159-182.
79. Wagner JC, Bromberg MB HIV infection presenting with motor axonal variant of Guillain-Barré Syndrome. J Clin Neuromuscul Dis 2007, 9:303-305.
80. Teo EC, Azwra A, Jones RL, Gazzard BG, Nelson M Guillain-Barré syndrome following immune reconstitution after antiretroviral therapy for primary HIV infection. J HIV Ther 2007, 12:62-63.
81. Piliero PJ, Fish DG, Preston S, et al. Guillain-Barré syndrome associated with immune reconstitution. Clin Infect Dis 2003, 36:e111-e114.
82. Makela P, Howe L, Glover S, Ferguson I, Pinto A, Gompels M Recurrent Guillain-Barré syndrome as a complication of immune reconstitution in HIV. J Infect 2002, 44:47-49.
83. Moulignier A, Authier FJ, Baudrimont M, et al. Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol 1997, 41:438-445.
84. Itescu S, Winchester R Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome. Rheum Dis Clin North Am 1992, 18:683-697.
85. Basu D, Williams FM, Ahn CW, Reveille JD Changing spectrum of the diffuse infiltrative lymphocytosis syndrome. Arthritis Rheum 2006, 55:466-472.
86. Kazi S, Cohen PR, Williams F, Schempp R, Reveille JD The diffuse infiltrative lymphocytosis syndrome. Clinical and immunogenetic features in 35 patients. AIDS 1996, 10:385-391.
87. Itescu S, Brancato LJ, Buxbaum J, et al. A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med 1990, 112:3-10.
88. Chahin N, Temesgen Z, Kurtin PJ, Spinner RJ, Dyck PJ HIV lumbosacral radiculoplexus neuropathy mimicking lymphoma: diffuse infiltrative lymphocytosis syndrome (DILS) restricted to nerve?. Muscle Nerve 2010, 41:276-282.
89. Golbus JR, Gallagher G, Blackburn G, Cinti S Polyneuropathy associated with the diffuse infiltrative lymphocytosis syndrome. J Int Assoc Physicians AIDS Care 2012, 11:223-226.
90. McArthur CP, Subtil-DeOliveira A, Palmer D, et al. Characteristics of salivary diffuse infiltrative lymphocytosis syndrome in West Africa. Arch Pathol Lab Med 2000, 124:1773-1779.
91. Itescu S, Rose S, Dwyer E, Winchester R Certain HLA-DR5 and -DR6 major histocompatibility complex class II alleles are associated with a CD8 lymphocytic host response to human immunodeficiency virus type 1 characterized by low lymphocyte viral strain heterogeneity and slow disease progression. Proc Natl Acad Sci USA 1994, 91:11472-11476.
92. Vidal JE, Clifford D, Ferreira CM, Oliveira AC HIV-associated neuromuscular weakness syndrome in Brazil: report of the two first cases. Arq Neuropsiquiatr 2007, 65:848-851.
93. Estanislao L, Thomas D, Simpson D HIV neuromuscular disease and mitochondrial function. Mitochondrion 2004, 4:131-139.
94. Miller RG, Parry GJ, Pfaeffl W, Lang W, Lippert R, Kiprov D The spectrum of peripheral neuropathy associated with ARC and AIDS. Muscle Nerve 1988, 11:857-863.
95. Fuller GN, Jacobs JM, Guiloff RJ Nature and incidence of peripheral nerve syndromes in HIV infection. J Neurol Neurosurg Psychiatry 1993, 56:372-381.
96. So YT, Olney RK Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann Neurol 1994, 35:53-58.
97. Piliero PJ, Estanislao L, Simpson D Diaphragmatic paralysis due to isolated phrenic neuropathy in an HIV-infected man. Neurology 2004, 62:154-155.
98. Chen-Plotkin AS, Christopoulos KA, Venna N Demyelinating polyneuropathy and herpes simplex lumbosacral radiculitis in a patient with chronic HIV infection. AIDS 2007, 21:1663-1664.
99. Estanislao LB, Morgello S, Simpson DM Peripheral neuropathies associated with HIV and hepatitis C co-infection: a review. AIDS 2005, 19(suppl 3):S135-S139.
100. Bradley WG, Verma A Painful vasculitic neuropathy in HIV-1 infection: relief of pain with prednisone therapy. Neurology 1996, 47:1446-1451.
101. Morgello S, Simpson DM Multifocal cytomegalovirus demyelinative polyneuropathy associated with AIDS. Muscle Nerve 1994, 17:176-182.
102. Said G, Lacroix C, Chemouilli P, et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 1991, 29:139-146.
103. Benatar MG, Eastman RW Human immunodeficiency virus-associated pure motor lumbosacral polyradiculopathy. Arch Neurol 2000, 57:1034-1039.
104. Cersosimo MG, Lasala B, Folgar S, Micheli F Epidural lipomatosis secondary to indinavir in an HIV-positive patient. Clin Neuropharmacol 2002, 25:51-54.
105. Masjuan J, Corral I, Fernandez-Ruiz LC Mycobacterial acute lumbosacral polyradiculopathy as the initial manifestation of AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 15:175.
106. Hernandez-Albujar S, Arribas JR, Royo A, Gonzalez-Garcia JJ, Pena JM, Vazquez JJ Tuberculous radiculomyelitis complicating tuberculous meningitis: case report and review. Clin Infect Dis 2000, 30:915-921.
107. Wadia NH, Dastur DK Spinal meningitides with radiculo-myelopathy. Clinical and radiological features. J Neurol Sci 1969, 8:239-260.
108. Moghtaderi A, Alavi Naini R Tuberculous radiculomyelitis: review and presentation of five patients. Int J Tuberc Lung Dis 2003, 7:1186-1190.
109. Marais S, Pepper DJ, Marais BJ, Torok ME HIV-associated tuberculous meningitis-diagnostic and therapeutic challenges. Tuberculosis 2010, 90:367-374.
110. Woolsey RM, Chambers TJ, Chung HD, McGarry JD Mycobacterial meningomyelitis associated with human immunodeficiency virus infection. Arch Neurol 1988, 45:691-693.
111. Leger JM, Henin D, Belec L, et al. Lymphoma-induced polyradiculopathy in AIDS: two cases. J Neurol 1992, 239:132-134.
112. Wiley CA, VanPatten PD, Carpenter PM, Powell HC, Thal LJ Acute ascending necrotizing myelopathy caused by herpes simplex virus type 2. Neurology 1987, 37:1791-1794.
113. Lanska MJ, Lanska DJ, Schmidley JW Syphilitic polyradiculopathy in an HIV-positive man. Neurology 1988, 38:1297-1301.
114. Miller RF, Fox JD, Thomas P, et al. Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients. J Neurol Neurosurg Psychiatry 1996, 61:456-460.
115. Gozlan J, el Amrani M, Baudrimont M, et al. A prospective evaluation of clinical criteria and polymerase chain reaction assay of cerebrospinal fluid for the diagnosis of cytomegalovirus-related neurological diseases during AIDS. AIDS 1995, 9:253-260.
116. Miller RG, Storey JR, Greco CM Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology 1990, 40:569-574.
117. Abad S, Touze E, Blanche P, et al. Shoulder girdle syndrome revealing primary HIV infection. Clin Infect Dis 2002, 34:1162-1163.
118. Finney KA, David L Brachial plexus neuritis in the context of acute HIV seroconversion illness: a case report. Int J STD AIDS 2012, 23:143-144.
119. Berger JR, Espinosa PS, Kissel J Brachial amyotrophic diplegia in a patient with human immunodeficiency virus infection: widening the spectrum of motor neuron diseases occurring with the human immunodeficiency virus. Arch Neurol 2005, 62:817-823.
120. Nishio M, Koizumi K, Moriwaka F, Koike T, Sawada K Reversal of HIV-associated motor neuron syndrome after highly active antiretroviral therapy. J Neurol 2001, 248:233-234.
121. Huang PP, Chin R, Song S, Lasoff S Lower motor neuron dysfunction associated with human immunodeficiency virus infection. Arch Neurol 1993, 50:1328-1330.
122. Henning F, Hewlett RH Brachial amyotrophic diplegia (segmental proximal spinal muscular atrophy) associated with HIV infection. J Neurol Neurosurg Psychiatry 2008, 79:1392-1394.
123. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010, 10:778-790.
124. Serrano P, Hernandez N, Arroyo JA, de Llobet JM, Domingo P Bilateral Bell palsy and acute HIV type 1 infection: report of 2 cases and review. Clin Infect Dis 2007, 44:e57-e61.
125. Keane JR Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology 1994, 44:1198-1202.
126. Babu K, Murthy KR, Rajagopalan N, Satish B Vision recovery in human immunodeficiency virus-infected patients with optic neuropathy treated with highly active antiretroviral therapy: a case series. Indian J Ophthalmol 2009, 57:315-318.
127. Calado S, Canas N, Viana-Baptista M, Ribeiro C, Mansinho K Multiple cranial neuropathy and HIV-2. J Neurol Neurosurg Psychiatry 2004, 75:660-661.
128. Moulignier A, Laloum L, Chauveau E, Gout O, Rozenbaum W HIV-1 related ischaemic trochlear nerve palsy. J Neurol 2003, 250:108-109.
129. Chand V, Sweeney C, Agger WA Mental neuropathy in patients with AIDS-associated malignant lymphoma. Clin Infect Dis 1997, 24:521-522.
130. Whitley RJ, Weiss H, Gnann JW, et al. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med 1996, 125:376-383.
131. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994, 330:896-900.
132. Belec L, Gherardi R, Georges AJ, et al. Peripheral facial paralysis and HIV infection: report of four African cases and review of the literature. J Neurol 1989, 236:411-414.
133. Nakamoto BK, Dorotheo EU, Biousse V, Tang RA, Schiffman JS, Newman NJ Progressive outer retinal necrosis presenting with isolated optic neuropathy. Neurology 2004, 63:2423-2425.
134. Compostella C, Compostella L, D'Elia R The symptoms of autonomic dysfunction in HIV-positive Africans. Clin Auton Res 2008, 18:6-12.
135. Acharjee S, Zhu Y, Maingat F, et al. Proteinase-activated receptor-1 mediates dorsal root ganglion neuronal degeneration in HIV/AIDS. Brain 2011, 134:3209-3221.
136. Payne BAI Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations. Nat Genet 2011, 43:806.